Beezaasan Explotech Share Price & Earnings Call Analysis
- Market cap
- ₹1,098 Cr
- P/E
- 82.91
- ROE
- 10.51%
- PEG
- 1.27
- Price to sales
- 5.18
- Debt to equity
- 0.24
- 52W high / low
- ₹769 / ₹186
- EBITDA margin
- 9.76%
- Net profit margin
- 6.34%
- Promoter holding
- 75.00%
- Sales (last year)
- ₹212 Cr
Incorporated in August 2013, Beezaasan Explotech Limited manufactures and supplies a comprehensive range of explosives and explosive accessories.[1]
Potential multibaggers · Q2 FY27
Potential multibaggers in Chemicals & Petrochemicals
on management's own guidance
- Strong growth2
- Strong growth1
- Strong growth3
Portfolio builder
Build your portfolio
from the top-ranked stocks
- 1. Pick 3–15 stocks
- 2. Choose large, mid or small cap and your sectors
- 3. Get a portfolio built from the rankings
Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.
Peers
Chemicals & Petrochemicals companies ranked on guidance
| # | Company | Revenue guided | Margin guided | Market cap | P/E |
|---|---|---|---|---|---|
| 1 | 40%+ | Up 0–2% | ₹234 Cr | 3.0 | |
| 2 | 40%+ | Flat | ₹3,888 Cr | 48.5 | |
| 3 | 40%+ | Flat | ₹3,514 Cr | 4.3 | |
| 4 | 40%+ | Flat | ₹180 Cr | 11.9 | |
| 5 | 40%+ | Flat | ₹138 Cr | 15.1 | |
| 6 | 20–40% | Up 2%+ | ₹1.70L Cr | 85.4 |
Sign up free to see every company in the sector ranking and track Beezaasan Explotech.
Pro shows every company guiding 40%+ revenue growth →Full Chemicals & Petrochemicals rankingBeezaasan Explotech announcements
All announcements →- Board / shareholder meeting outcomeNotableBeezaasan Explotech Limited completes EGM approving preferential equity issue on Oct 13, 2026
Financials of Beezaasan Explotech
Quarterly Results, Profit & Loss, Balance Sheet, Cash Flows, and Ratios are shown below as separate sections.
Financials of Beezaasan Explotech
Quarterly Results
Quarter-by-quarter operating performance
Financials of Beezaasan Explotech
Profit & Loss
Annual income statement trend
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Sales + | 36 | 58 | 142 | 229 | 187 | 215 | 212 |
| Expenses + | 34 | 55 | 135 | 220 | 175 | 194 | 193 |
| Operating Profit | 2 | 3 | 7 | 9 | 12 | 21 | 18 |
| OPM % | 5% | 5% | 5% | 4% | 6% | 10% | 9% |
| Other Income + | 0 | 0 | 0 | 0 | 0 | 1 | 2 |
| Interest | 1 | 1 | 2 | 3 | 3 | 3 | 1 |
| Depreciation | 0 | 1 | 1 | 2 | 2 | 2 | 3 |
| Profit before tax | 0 | 2 | 4 | 4 | 7 | 16 | 16 |
| Tax % | 94% | 34% | 24% | 26% | 24% | 25% | 24% |
| Net Profit + | 0 | 1 | 3 | 3 | 5 | 12 | 12 |
| EPS in Rs | 0.02 | 1.75 | 4.36 | 4.20 | 5.36 | 9.52 | 7.79 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
Financials of Beezaasan Explotech
Balance Sheet
Capital structure and asset base
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Equity Capital | 4 | 6 | 7 | 7 | 10 | 13 | 15 |
| Reserves | -0 | 1 | 5 | 7 | 14 | 83 | 138 |
| Borrowings + | 13 | 18 | 24 | 44 | 34 | 22 | 35 |
| Other Liabilities + | 4 | 3 | 7 | 4 | 9 | 9 | 12 |
| Total Liabilities | 21 | 28 | 43 | 63 | 67 | 127 | 200 |
| Fixed Assets + | 8 | 16 | 19 | 24 | 30 | 34 | 47 |
| CWIP | 5 | 0 | 0 | 3 | 2 | 12 | 3 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 53 |
| Other Assets + | 8 | 13 | 24 | 35 | 36 | 82 | 97 |
| Total Assets | 21 | 28 | 43 | 63 | 67 | 127 | 200 |
Financials of Beezaasan Explotech
Cash Flows
Operating, investing and financing cash movement
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Cash from Operating Activity + | 2 | -0 | -0 | 17 | 7 | 4 | |
| Cash from Investing Activity + | -5 | -3 | -5 | -12 | -6 | -35 | |
| Cash from Financing Activity + | 4 | 3 | 6 | 1 | -6 | 49 | |
| Net Cash Flow | -0 | 0 | 0 | 7 | -4 | 18 | |
| Free Cash Flow | -3 | -10 | -5 | 11 | 2 | -13 | |
| CFO/OP | 97% | -4% | -2% | 203% | 67% | 25% |
Financials of Beezaasan Explotech
Ratios
Working capital efficiency and return ratios
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Debtor Days | 51 | 36 | 28 | 17 | 13 | 11 | 22 |
| Inventory Days | 31 | 49 | 34 | 25 | 47 | 52 | 80 |
| Days Payable | 43 | 19 | 13 | 3 | 3 | 0 | 7 |
| Cash Conversion Cycle | 39 | 66 | 49 | 40 | 57 | 63 | 95 |
| Working Capital Days | -24 | -2 | 12 | -12 | -3 | 40 | 47 |
| ROCE % | 11% | 18% | 16% | 18% | 21% | 11% |
Momentum score · price trend
99 out of 100 — Strengthening
Over the past year its share price has done better than most of the stocks we track.
| Period | Share price change | Better than … of 1,910 stocks |
|---|---|---|
| Last 12 months | +170.4% | 97% |
| Last 6 months | +196.0% | 99% |
| Last 3 months | +81.2% | 99% |
How we calculate it
“Better than 30%” means that over that period the share price did better than 30 out of every 100 stocks we track (1,910 Indian companies worth ₹500 Cr or more, with at least a year of prices).
The score weighs the longer periods more: 40% × 12-month + 40% × 6-month + 20% × 3-month. For Beezaasan Explotech: 0.4 × 97 + 0.4 × 99 + 0.2 × 99 = 99.
Strengthening is 70 and above, Steady 40 to 70, Cooling below 40. Scores are recalculated every night after the market closes.
Full methodology →This describes only how the share price has moved up to 2 Nov 2026, compared with other stocks. It says nothing about the business, and it is not a prediction, a price target or a recommendation to buy or sell.
Continue your research
Others in Chemicals & Petrochemicals this season
- J.G.Chemicals (Q2 FY27)
Q2 FY27 Revenue from Operations: ₹3,610 million, up 63.9% YoY (₹2,203 million in Q2 FY26) (Page 23) . Key investor presentation takeaways from J.G.Chemicals Ltd
- Lords Chloro (Q2 FY27)
115.40 Crore, up 17.34% YoY from Rs. Key investor presentation takeaways from Lords Chloro Alkali Ltd's Q2 FY27 investor presentation — and how it ranks against
- Camlin Fine (Q2 FY27)
Q2 FY27 revenue: Rs 4,915 mn, up 9.15% YoY from Rs 4,503 mn in Q2 FY26 (Page 6, 9) . Key investor presentation takeaways from Camlin Fine Sciences Ltd's Q2 FY27
- Gujarat Fluoroch (Q2 FY27)
Consolidated Q2FY27 revenue: ₹1,760 crore, up 45% YoY (Q2FY26: ₹1,210 crore). Key investor presentation takeaways from Gujarat Fluorochemicals Ltd's Q2 FY27 inv
